What’s the best way to improve commercial performance? For biopharma companies, according to a report from Accenture, the answer is investment and innovation. In a five-year study of 15 drugmakers, ...

Fusion energy, long the holy grail of clean energy enthusiasts, has endured decades of research, often with considerable financial strain. While privately funded tech tycoons and governments alike are ...

Biopharmaceutical companies are looking for go-to-market approaches that go beyond customer expectations. Starting with a revolutionized technology platform allows these organizations to create value ...

For the first time since GPT-2 in 2019, OpenAI is releasing new open-weight large language models. It's a major milestone for a company that has increasingly been accused of forgoing its original ...

In my previous column, I discussed how pharmaceutical and medical device companies are adapting their commercial model approaches in critical areas to address growing economic, market and other ...

The high costs of development and training and the lack of pricing transparency put commercial large language models out of reach for many companies. Open source models could change that. Large ...

The company said paid tiers will fund the future of its AI research. The company said paid tiers will fund the future of its AI research. is a reporter who writes about AI. She also covers the ...